Skip to content
Governance Register
US nonprofit · EIN 462216869 · San Antonio, TXiSource and licenceOrganisation record IRS Exempt Organizations Business Master File (EIN 462216869) - NTEE activity code, address.Board and officers IRS Form 990 annual filings, Part VII (directors, trustees, officers, key employees), read year by year to observe time served.Finances by year IRS Form 990 e-file data - total revenue and total expenses by tax year.Principal officer IRS Form 990-N (e-Postcard) - principal officer named for tax year 2014.Deductibility IRS Publication 78 data (code PC), downloaded 18 October 2026.Licence US Federal Government public domain.How we handle data

BBG Advanced Therapies's network

1 personExplore in 3DiThe large node is BBG Advanced Therapies. The map shows the people and organisations in the public record, two steps out at most. Hover a node to focus its connections; click one to open it.

Principal officer

iSmall organisations file the Form 990-N e-Postcard, which names one principal officer and gives no role or board list. Taken from the filing for tax year 2014.
NameSourceTax year
Linda MyersIRS Form 990-N (e-Postcard); role not stated2014

Officers and senior leadership

17 listediNamed in Part VII as officers, key employees or highest-compensated staff - not board members, shown for completeness.
NameTitle as filedOn the filings
Amanda Therese WhitelonisPrincipal Global Market Development (effective 11/03/2024)since 2022
Becky CAPSVP COO, Gencure (Thru 09/22)since 2018
Christie Elaine MaloneDirector, Business Developmentsince 2019
Christopher BarnettSenior Director, Process Develsince 2019
Christopher Keith BronaughDirector, Tissue Hospital Oper2020
Geoffrey KindtGeneral Manager, Biomanufacturing (thru 11/02/2024)2024
Jessica Ann RaleyDirector, Clinical & Researchsince 2019
Kathryn Ann MillarSr Scientific and Sales Specia2022
Mari Lane SalmiSr. Director, Process Dev & Cell Therapiessince 2022
Michael James FiskeVP Cell Manufacturingsince 2018
Milton Masayuki PollardVP, GENCURE OPERATIONS (thru 07/09/2024)since 2022
Miguel GarzaDirector, Operations Biomanufacturing2024
Pamela Brown BaerVP Operationssince 2018
Richard JuarezExecutive Director, Tissue Cen2018
Rogelio ZamilpaSr. Director, MFG Sciencessince 2018
Sean Allan ThompsonSr Director Bus Ops & New Prod2018
William G Elliott IIIDirector Tissue Center Donor S2018

About

Legal name
BBG Advanced Therapies
EIN
462216869
Address
6211 Ih 10 West, San Antonio, TX, 78201-2023
State
Texas
Activity (NTEE)
E61 Health care
IRS classification
501(c)03 (tax-exempt under section 501(c)(3) where shown)
Classified purpose
Health Care
Size band
8 (IRS master file code)
IRS ruling date
1 July 2014
Status
Code 01 (unconditional exemption)
IRS Publication 78
PC (contributions deductible)
Principal officer
Linda Myers (Form 990-N, tax year 2014)

Filed finances

1 yeariTotals as filed on the IRS Form 990 (revenue and expenses), by tax year.
Tax yearTotal revenueTotal expensesSurplus or deficit
2024$5.4m$16mDeficit $10.6m

As filed on the IRS Form 990. US dollars.

State registration

1 entityiBusiness-entity registers published by US states. These records are matched to this organisation by name and state, not by EIN, and are labelled as likely matches. Street addresses are not shown.
Bbg Advanced Therapies likely matchiMatched by exact name and state (and ZIP where shown). State registers do not publish EINs, so this is not a confirmed match. Source: Texas Comptroller of Public Accounts, entity data (data.texas.gov 9cir-efmm). Licence not stated. Data last fetched 18 October 2026.
State
Texas
Entity type
nonprofit corporation
Status
Active
Formed
6 March 2013
Registered agent
Not stated

This register does not publish officers or directors.